We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Shellfish Exoskeletons May Reduce Radiation Poisoning

By HospiMedica staff writers
Posted on 03 Oct 2006
An investigator is currently is investigating a novel approach based on a readily available biomaterial that could potentially be used to reduce an individual's radiation dose.

At present, there are no effective methods to isolate and remove radionuclides from humans in the event of a detonation of a suitcase-sized nuclear bomb by a terrorist in a major city. Dr. Tatiana Levitskaia, a scientist from Pacific Northwest National Laboratory (Richmond, WA, USA), reported on the technology at the U.S. national meeting of the American Chemical Society, held in September 2006 in San Francisco (CA, USA).

Chitosan is a natural and safe compound that has been found to be an effective chelator for a wide range of nuclides. Chitosan is obtained from chitin and found in the exoskeletons of many invertebrates such as crabs and prawns. It is one of the most abundant, readily available, and renewable natural biopolymers, second only to cellulose.

Some chitosan materials can be chemically engineered to improve their affinity to specific radionuclides. By binding to radionuclides, scientists hypothesize that chitosan may inhibit deposition in bones and vital organs such as the liver and kidney, and speed up removal from the body.

Dr. Levitskaia's investigation is targeted at finding a natural chelator such as chitosan that can safely and effectively rid the body of diverse radionuclides such as actinides, cobalt, strontium, and radium. Currently, Dr. Levitskaia's research involves the removal of cobalt from living tissues in laboratory rats. Results are expected in the fall of 2006.



Related Links:
Pacific Northwest National Laboratory

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Plasma Freezer
iBF125-GX
New
Mini C-arm Imaging System
Fluoroscan InSight FD

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization